David (Avi) Page
About David (Avi) Page
David (Avi) Page serves as the Sr. Director at Kite Pharma, where he has worked since 2020, overseeing the Process Validation and Statistical Sciences & Analytics departments. He has extensive experience in biopharmaceutical engineering, having held various roles at companies such as KBI Biopharma, Genentech, and Abbott Laboratories.
Work at Kite Pharma
David Page serves as the Senior Director at Kite Pharma, a position he has held since 2020. He is based in Santa Monica, California. In this role, he heads the Process Validation and Statistical Sciences & Analytics departments. Additionally, he leads the Materials & Process Engineering team and is responsible for overseeing the global technical transfer processes within the organization. His contributions are integral to the development and validation of innovative therapies at Kite Pharma.
Previous Experience in Biopharma
Prior to his current role, David Page held several positions in the biopharmaceutical industry. He worked at KBI Biopharma as Director of Manufacturing Sciences and Technology from 2019 to 2020. Before that, he was a Principal Engineer at Genentech from 2013 to 2017. His career also includes roles at Abbott Laboratories as a Development Engineer and at CRB Consulting Engineers, Inc. as a Senior Bioprocess Engineer. These positions provided him with extensive experience in process development and engineering.
Education and Expertise
David Page earned a Bachelor of Science degree in Chemical Engineering from Northwestern University, where he studied from 1993 to 1998. His educational background laid the foundation for his expertise in bioprocess engineering and manufacturing sciences. Throughout his career, he has developed a strong skill set in process validation, statistical analysis, and technical transfer processes.
Career Progression
David Page's career spans over two decades in the biopharmaceutical sector. He began his professional journey at Abbott Laboratories as a Development Engineer from 1998 to 2003. He then transitioned to roles at Lonza Biologics, MedImmune, and KBI Biopharma, where he advanced to Associate Director of Downstream Manufacturing Sciences. His diverse experiences across various companies have equipped him with a comprehensive understanding of the industry.